Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them
Andrew Bateman
Consultant Clinical Oncologist
Specialty
Clinical oncology
Sub-specialty
Gastrointestinal cancer
Training
Dr Andrew Bateman was appointed Senior Lecturer, Cancer Sciences, University of Southampton in 2002 and was recipient of a Cancer Research UK Clinician Scientist award. He had graduated from St Bartholomew’s Hospital Medical School in 1989 and undertaken general medical training in London and the South East. He was appointed to a Clinical Oncology Registrar Training post at the Hammersmith Hospital in 1993, spent a year (’95-’96) in Christchurch, New Zealand, completing the FRCR in ’97. He then entered research as an ICRF clinical research fellow in the laboratory of Dr Richard Vile, initially at the Hammersmith and then subsequently in the Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota.
In 2001-2 Dr Bateman completed his Clinical Oncology training at Mount Vernon Hospital, before obtaining a CR UK Clinician Scientist Fellowship and moving to Southampton. Here he has developed a clinical practice in gastrointestinal malignancy, a focus in clinical trials, and research in cancer immunology and immunotherapy.
Qualifications
MB BS, University of London (1989)
MRCP, Royal College of Physicians (1992)
FRCR, Royal College of Radiologists (1997)
PhD, Open University (2002)
Appointments Held
Clinical Research Fellow, Imperial Cancer Research Fund, 1997-98
Research Associate, Molecular Medicine Program, Mayo Clinic 1998-2001
Clinical Oncology Senior Registrar, Mount Vernon Hospital, 2001 – 2002
Senior Lecturer, Consultant Clinical Oncologist, University of Southampton 2002 – present
Research
Information on Dr Bateman’s research and publications can be found on the University of Southampton website.
How the money raised is spent
See all stories
PLANETS funds novel 3D printed livers to aid complex surgery
Surgeons in Southampton are the first in the UK to begin using 3D printed models of patients’ livers to help them perform a complex cancer operation. Converting the data available from CT and MRI scans of patients with hilar cholangiocarcinoma – a type of bile duct cancer – into 3D models will enable better planning and decision-making prior to surgery. …